BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33846795)

  • 21. MicroRNA-140 Represses Esophageal Cancer Progression via Targeting ZEB2 to Regulate Wnt/β-Catenin Pathway.
    Yang S; Li X; Shen W; Hu H; Li C; Han G
    J Surg Res; 2021 Jan; 257():267-277. PubMed ID: 32862055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. URG11 promotes proliferation and induced apoptosis of LNCaP cells.
    Sun C; Zhang G; Cheng S; Qian H; Li D; Liu M
    Int J Mol Med; 2019 May; 43(5):2075-2085. PubMed ID: 30864678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SEC61 translocon subunit gamma enhances low-dose cisplatin-induced cancer-stem cell properties of head and neck squamous cell carcinoma via enhancing Ca
    Bu X; Zhang J; Sun H; Wang W; Ma X; Sun L
    J Dent Sci; 2023 Oct; 18(4):1685-1692. PubMed ID: 37799908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
    Zhuang XH; Liu Y; Li JL
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
    Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
    Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Songorine suppresses cell growth and metastasis in epithelial ovarian cancer via the Bcl‑2/Bax and GSK3β/β‑catenin signaling pathways.
    Zhang H; Dong R; Zhang P; Wang Y
    Oncol Rep; 2019 May; 41(5):3069-3079. PubMed ID: 30896826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knockdown of Nemo‑like kinase promotes metastasis in non‑small‑cell lung cancer.
    Shi C; Xu L; Tang Z; Zhang W; Wei Y; Ni J; Zhang S; Feng J
    Oncol Rep; 2019 Sep; 42(3):1090-1100. PubMed ID: 31322229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.
    Li Y; Chen D; Su Z; Li Y; Liu J; Jin L; Shi M; Jiang Z; Qi Z; Gui Y; Yang S; Mao X; Wu X; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1420-6. PubMed ID: 26648244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA ENST00000434223 inhibits the progression of renal cancer through Wnt/hygro-catenin signaling pathway.
    Luo NQ; Ma DR; Yang XC; Liu Y; Zhou P; Guo LJ; Huang XD
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6868-6877. PubMed ID: 31486486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of STC2 gene silencing on colorectal cancer cells.
    Li Q; Zhou X; Fang Z; Pan Z
    Mol Med Rep; 2019 Aug; 20(2):977-984. PubMed ID: 31173256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.
    Liu XL; Pan WG; Li KL; Mao YJ; Liu SD; Zhang RM
    Cancer Biother Radiopharm; 2020 Jun; 35(5):377-386. PubMed ID: 31971830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma.
    Duan X; Li W; Hu P; Jiang B; Yang J; Zhou L; Mao X; Tian B
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33078826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of E‑cadherin expression mediated by a novel dsRNA suppresses the growth and metastasis of bladder cancer cells by inhibiting β-catenin/TCF target genes.
    Li C; Liu J; Zhang Q; Cui K; Ge Q; Wang C; Chen Z
    Int J Oncol; 2018 Jun; 52(6):1815-1826. PubMed ID: 29620261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HNF‑4α downregulation promotes tumor migration and invasion by regulating E‑cadherin in renal cell carcinoma.
    Gao Y; Yan Y; Guo J; Zhang Q; Bi D; Wang F; Chang Z; Lu L; Yao X; Wei Q
    Oncol Rep; 2019 Sep; 42(3):1066-1074. PubMed ID: 31322246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary results indicate increased expression of miR-184 in patients with renal carcinoma.
    Yang J; Lai CC; Xian ZM; Wang WQ; Xu BL
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6878-6887. PubMed ID: 31486487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Jam3 promotes migration and suppresses apoptosis of renal carcinoma cell lines.
    Li X; Yin A; Zhang W; Zhao F; Lv J; Lv J; Sun J
    Int J Mol Med; 2018 Nov; 42(5):2923-2929. PubMed ID: 30226554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-155 affects renal carcinoma cell proliferation, invasion and apoptosis through regulating GSK-3β/β-catenin signaling pathway.
    Wei RJ; Zhang CH; Yang WZ
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5034-5041. PubMed ID: 29228417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silencing MTA1 by RNAi reverses adhesion, migration and invasiveness of cervical cancer cells (SiHa) via altered expression of p53, and E-cadherin/β-catenin complex.
    Rao Y; Wang H; Fan L; Chen G
    J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):1-9. PubMed ID: 21336715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
    Xu R; Hu J; Zhang T; Jiang C; Wang HY
    Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
    He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
    J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.